Hepatic preconditioning of doxorubicin in stop-flow chemotherapy: NF-κB/IκB-α pathway and expression of HSP72

Figure 2 Western blot analysis of NF-κB presentation (A) in liver nuclear extracts, IκB-α expression (B) and immunoprecipitation/Western blot analysis of p-IκB-α expression (C) in liver cytoplasmic extracts at different time points, i. e. before SFC, at the end of SFC (20 min), 30 min after the restoration of the abdominal circulation, 3 h after the restoration of the abdominal circulation, 6 h after the restoration of the abdominal circulation. WB, Western blot, IP, Immunoprecipitation.